274
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Combined use of oestradiol and progesterone to support luteal phase in antagonist intracytoplasmic sperm injection cycles of normoresponder women: a case-control study

, ORCID Icon, , ORCID Icon, , , & show all

References

  • Aghahosseini M, Aleyassin A, Khodaverdi S, Esfahani F, Mohammadbeigi R, Movahedi S, et al. 2011. Oestradiol supplementation during the luteal phase in poor responder patients undergoing in vitro fertilization: a randomized clinical trial. Journal of Assisted Reproduction and Genetics 28:785–790.
  • Ceyhan ST, Basaran M, Kemal Duru N, Yilmaz A, Göktolga U, Baser I. 2008. Use of luteal oestrogen supplementation in normal responder patients treated with fixed multidose GnRH antagonist: a prospective randomized controlled study. Fertility and Sterility 89:1827–1830.
  • Committee on Practice Bulletins—Gynecology. 2015. The American College of Obstetricians and Gynecologists Practice Bulletin no. 150. Early pregnancy loss. Obstetrics & Gynecology 125:1258–1267.
  • Drakakis P, Loutradis D, Vomvolaki E, Stefanidis K, Kiapekou E, Anagnostou E, et al. 2007. Luteal oestrogen supplementation in stimulated cycles may improve the pregnancy rate in patients undergoing in vitro fertilization/intracytoplasmic sperm injection-embryo transfer. Gynecological Endocrinology 23:645–652.
  • Engmann L, DiLuigi A, Schmidt D, Benadiva C, Maier D, Nulsen J. 2008. The effect of luteal phase vaginal oestradiol supplementation on the success of in vitro fertilization treatment: a prospective randomized study. Fertility and Sterility 89:554–561.
  • Farhi J, Weissman A, Steinfeld Z, Shorer M, Nahum H, Levran D. 2000. Oestradiol supplementation during the luteal phase may improve the pregnancy rate in patients undergoing in vitro fertilization–embryo transfer cycles. Fertility and Sterility 73:761–766.
  • Fatemi HM, Kolibianakis EM, Camus M, Tournaye H, Donoso P, Papanikolaou E, Devroey P. 2006. Addition of oestradiol to progesterone for luteal supplementation in patients stimulated with GnRH antagonist/rFSH for IVF: a randomized controlled trial. Human Reproduction (Oxford, England) 21:2628–2632.
  • Ghanem M, Bedairy MH, Helal AS, Shaaban A. 2015. Is adding oestradiol (e2) to progesterone (P) luteal support in high responder long GnRH agonist ICSI cycles detrimental to outcome? Randomized controlled trial (RCT). ASRM 104:e224.
  • Ghanem ME, Sadek EE, Elboghdady LA, Helal AS, Gamal A, Eldiasty A, et al. 2009. The effect of luteal phase support protocol on cycle outcome and luteal phase hormone profile in long agonist protocol intracytoplasmic sperm injection cycles: a randomized clinical trial. Fertility and Sterility 92:486–493.
  • Huang N, Situ B, Chen X, Liu J, Yan P, Kang X, et al. 2015. Meta-analysis of oestradiol for luteal phase support in in vitro fertilization/intracytoplasmic sperm injection. Fertility and Sterility 103:367–373.e5.
  • Hutchinson-Williams KA, Lunenfeld B, Diamond MP, Lavy G, Boyers SP, DeCherney AH. 1989. Human chorionic gonadotropin, oestradiol, and progesterone profiles in conception and nonconception cycles in an in vitro fertilization program. Fertility and Sterility 52:441–445.
  • Jee BC, Suh CS, Kim SH, Kim YB, Moon SY. 2010. Effects of oestradiol supplementation during the luteal phase of in vitro fertilization cycles: a meta-analysis. Fertility and Sterility 93:428–436.
  • Kutlu T, Ozkaya E, Ayvaci H, Devranoglu B, Sanverdi I, Sahin Y, et al. 2016. Area under curve of temporal estradiol measurements for prediction of the detrimental effect of estrogen exposure on implantation. International Journal of Gynecology & Obstetrics 135:168–171.
  • Kutlusoy F, Guler I, Erdem M, Erdem A, Bozkurt N, Biberoglu EH, Biberoglu KO. 2014. Luteal phase support with estrogen in addition to progesterone increases pregnancy rates in in vitro fertilization cycles with poor response to gonadotropins. Gynecological Endocrinology 30:363–366.
  • Kwon S-K, Kim C-H, Lee K-H, Jeon IK, Ahn J-W, Kim S-H, et al. 2013. Luteal oestradiol supplementation in gonadotropin-releasing hormone antagonist cycles for infertile patients in vitro fertilization. Clinical and Experimental Reproductive Medicine 40:131–134.
  • Lukaszuk K, Liss J, Lukaszuk M, Maj B. 2005. Optimization of oestradiol supplementation during the luteal phase improves the pregnancy rate in women undergoing in vitro fertilization–embryo transfer cycles. Fertility and Sterility 83:1372–1376.
  • Madkour WA, Noah B, Abdel Hamid MS, Zaheer H, Al-Bahr A, Shaeer M, Moawad A. 2016. Luteal phase support with oestradiol and progesterone versus progesterone alone in GnRH antagonist ICSI cycles: a randomized controlled study. Human Fertility 19:142–149.
  • Makrigiannakis A, Minas V. 2007. Mechanisms of implantation. Reproductive Biomedicine Online 14:102–109.
  • Ozkaya E, Kutlu T, Abide Yayla C, Kayatas Eser S, Sanverdi I, Devranoglu B. 2018. Area under the curve of temporal estrogen and progesterone measurements during assisted reproductive technology: which hormone is the main determinant of cycle outcome? Journal of Obstetrics and Gynaecology Research 44:263–269.
  • Pritts EA, Atwood AK. 2002. Luteal phase support in infertility treatment: a meta-analysis of the randomized trials. Human Reproduction 17:2287–2299.
  • The American Fertility Society. 1985. Revised American Fertility Society classification of endometriosis. Fertility and Sterility 43:351–352.
  • Stensen MH, Tanbo T, Storeng R, Byholm T, Fèdorcsak P. 2010. Routine morphological scoring systems in assisted reproduction treatment fail to reflect age-related impairment of oocyte and embryo quality. Reproductive BioMedicine Online 21:118–125.
  • van der Linden M, Buckingham K, Farquhar C, Kremer JAM, Metwally M. 2015. Luteal phase support for assisted reproduction cycles. The Cochrane Database of Systematic Reviews CD009154.
  • Var T, Tonguc EA, Doğanay M, Gulerman C, Gungor T, Mollamahmutoglu L. 2011. A comparison of the effects of three different luteal phase support protocols on in vitro fertilization outcomes: a randomized clinical trial. Fertility and Sterility 95:985–989.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.